adverse-reactions

Documents about adverse-reactions

• Adverse Drug Reactions in Pediatrics: Experience of a Regional Pharmacovigilance Center#842447ClinicalTrials.gov
• Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers#911996ClinicalTrials.gov
• Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study#853260ClinicalTrials.gov
• Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years#837889ClinicalTrials.gov
• Risk factors for adverse drug reactions in pediatric inpatients: a cohort study#473192Repositório Institucional da Universidade Federal de Sergipe
• Severe Cutaneous Adverse Reactions in Thailand#1184278ClinicalTrials.gov
• Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients#1074145ClinicalTrials.gov
• Monitoring For Adverse Psychosocial Outcomes In Survivors Of Severe Cutaneous Adverse Reactions#397775EliScholar
• Serious Adverse Drug Reaction and Their Preventability#1007529ClinicalTrials.gov
• Adverse Drug Event Prevention Using Structured Pharmacist Review#1072969ClinicalTrials.gov
• Sins and Risks in Underreporting Suspected Adverse Drug Reactions#709065PhilArchive
• Adverse drug reactions in high-risk pregnant women: a prospective study#928257Repositório Institucional da Universidade Federal de Sergipe
• Effect of Amobarbital Sodium Combined With Low-dose Propofol on Hemodynamics During Induction and Perioperative Adverse Reactions#1044913ClinicalTrials.gov
• Evaluating ActionADE in Reducing Adverse Drug Reactions#883572ClinicalTrials.gov
• Adverse Drug Reactions to Cancer Therapies in Patients with Depression: Insights from VigiBase#1306756ClinicalTrials.gov
• Adverse Drug Reactions in Older Subjects#1185917ClinicalTrials.gov
• The Knowledge, Attitudes and Practices of Healthcare Workers on Drug Hypersensitivity Reactions in Children#854183ClinicalTrials.gov
• Safety Evaluation of Adverse Reactions in Diabetes#272260ClinicalTrials.gov
• Advances in Ontology-Based Mining of Adverse Drug Reactions#1533934arXiv (All)
• Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection#811144ClinicalTrials.gov
• Integrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care System#1382405ClinicalTrials.gov
• Severe Cutaneous Adverse Reactions Associated With Newer-Generation Antiseizure Medications: A Real-World Pharmacovigilance Study Based on FAERS and JADER#266507Europe PMC
• Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients#1231064ClinicalTrials.gov
• A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems#1362189ClinicalTrials.gov
• Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults#885594ClinicalTrials.gov
• Prevalence, severity and predictors of Antipsychotic-Related Adverse Drug Reactions at the Psychiatry Clinic of a Regional Referral Hospital in Uganda#453118PLOS
• 50 Years of Immunization—Steps Forward#486674Directory of Open Access Books
• Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) Drugs#1295129ClinicalTrials.gov
• Analysis of anticancer drug associated adverse reactions in depressive patients from vigibase#676795HAL (France)
• Assessment of knowledge and attitude of adverse drug reactions among healthcare professionals in Bangladesh#722481PhilArchive
• Adverse Drug Reactions of Different Brands of Ceftazidime Injection#1376363ClinicalTrials.gov
• Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France#147543HAL (France)
• A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment#1363285ClinicalTrials.gov
• Adverse events in different administration routes of Edaravone: A pharmacovigilance study based on the FDA adverse event reporting system#10246PLOS
• CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs#862147ClinicalTrials.gov
• Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors#893029ClinicalTrials.gov
• An Exploratory Study of Genetic and Clinical Factors for Serious Skin Reactions Among Users of Eslicarbazepine Acetate#1451747ClinicalTrials.gov
• Pregabalin-associated adverse drug reactions: A real-world pharmacovigilance study using WHO-VigiAccess.#636405NCBI PubMed Central
• DOAC ADRs Retrospective Study on Genetic Variations#1409893ClinicalTrials.gov
• Drug-Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper#635310HAL (France)
• Passive surveillance of adverse events following immunization for National Immunization Program vaccines in Shenyang, China, 2009-2024.#404604PubMed
• Characterization of adverse reactions to two antihistamine drugs: A descriptive analysis from WHO-VigiAccess.#450134NCBI PubMed Central
• Pharmacogenomics Registry to Assess Clinical Utility#1162879ClinicalTrials.gov
• Association Between Genetic Variant Scores and DOACs (DARES2)#1195997ClinicalTrials.gov
• Impact of Pharmacotherapeutic Education on Medication Adherence and Adverse Outcomes in Type 2 Diabetes#845731ClinicalTrials.gov
• Quantifying the Attentive Behaviors of Older Adults During Over-the-counter Drug Selection#855854ClinicalTrials.gov
• The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial#967972ClinicalTrials.gov
• Compliance and Tolerance to Oral AntiBiotherapy in Osteoarticular Infections (OTABIO)#1375241ClinicalTrials.gov
• Consumers' experiences and perspectives on reporting adverse drug reactions using digital tools: a qualitative study.#785478NCBI PubMed Central
• Prevention and Pharmacological Management of Cardiac Adverse Drug Reactions Induced by Drugs Used in Oncology.#1165224ClinicalTrials.gov